Home › Rheumatoid Arthritis › Arizona
Rheumatoid Arthritis clinical trials in Arizona
10 studies for Rheumatoid Arthritis are looking for participants at sites in Arizona.
Cities in Arizona
A Study of AZD0120 in Autoimmune Diseases
- Research Site, Tucson
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Nov 10, 2026 · NCT07295847Study of PTC844 in Participants With Active Rheumatoid Arthritis
- AARA Clinical Research - Arizona Arthritis and Rheumatology Associates - Chandler, Chandler
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Flagstaff, Flagstaff
- AARA Clinical Research - Arizona Arthritis & Rheumatology Associates - Phoenix, Phoenix
RecruitingPhase 2
Ages 18 to 70 · All sexes · Updated Nov 6, 2026 · NCT07779616A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
- Arizona Arthritis & Rheumatology Associates, P.C., Avondale
- SunValley Arthritis Center Ltd., Peoria
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 16, 2026 · NCT07137598A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
- Research Site, Glendale
- Research Site, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 9, 2026 · NCT07276581A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
- Sun Valley Arthritis Center /ID# 278331, Peoria
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 8, 2026 · NCT06972446A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- HonorHealth Research and Innovation Institute, Scottsdale
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT06570798RA-PRO PRAGMATIC TRIAL
- SunValley Arthritis Center, Ltd, Peoria
- University of Arizona, Tucson
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT04692493AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
- Artiva Investigational Site Phoenix, Phoenix
- Artiva Investigational Site Tucson, Tucson
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT06991114Study of Single Doses of SBT777101 in Subjects With Rheumatoid Arthritis
- Mayo Clinic, Scottsdale
RecruitingPhase 1
Ages 18 to 70 · All sexes · Updated Jun 30, 2026 · NCT06201416A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis
- Arizona Research Center, Phoenix
RecruitingPhase 1Healthy volunteers welcome
Ages 18 to 75 · All sexes · Updated Jun 23, 2026 · NCT07258849From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.